• U 46619: Precision Tool for Platelet Aggregation and Vascula

  2026-04-26

  U 46619 (11,9 epoxymethano-prostaglandin H2) stands out as a highly selective agonist for dissecting platelet and vascular signaling, enabling reproducible, high-sensitivity modeling of cardiovascular dynamics. This article translates advanced research and field-tested protocols into actionable strategies for applied platelet aggregation, serotonin release, and renal vasoconstriction studies.

• PEDV Infection Disrupts NHE3 Activity, Driving Diarrhea in P

  2026-04-25

  This study demonstrates that porcine epidemic diarrhea virus (PEDV) infection in neonatal piglets specifically reduces the activity and membrane localization of the Na+/H+ exchanger NHE3, a key regulator of intestinal sodium absorption. These findings clarify the molecular basis for PEDV-induced diarrhea and highlight the importance of NHE3 in gut epithelial physiology.

• Refining In Vitro Drug Response Metrics in Cancer Research

  2026-04-24

  Schwartz (2022) introduces a comparative framework for in vitro drug response evaluation, distinguishing between growth arrest and cell death in anti-cancer drug assays. This approach enhances the interpretation of kinase inhibitor effects, supporting more precise modeling of therapeutic impact in chronic myeloid leukemia and related cancer research.

• Sulfo-NHS-SS-Biotin: Protocol-Driven Protein Labeling Guide

  2026-04-24

  Sulfo-NHS-SS-Biotin is designed for efficient, water-soluble biotinylation of primary amines, particularly for cell surface protein labeling and affinity purification workflows. Researchers should use this reagent where reversible biotin conjugation and high aqueous solubility are required, but avoid scenarios needing intracellular labeling or long-term solution stability.

• AMPK Restricts Autophagy by Inhibiting ULK1 During Energy St

  2026-04-23

  This study redefines the role of AMPK in cellular energy stress, demonstrating that AMPK inhibits, rather than activates, ULK1-mediated autophagy during glucose deprivation. These findings reshape our understanding of energy sensing and autophagy regulation, with implications for research on cell survival mechanisms under nutrient limitation.

• Pexidartinib (PLX3397): Technical Guidance for CSF1R Inhibit

  2026-04-23

  Pexidartinib (PLX3397) is a selective ATP-competitive CSF1R inhibitor designed for research applications involving macrophage modulation and tumor microenvironment studies. It is best suited for workflows investigating CSF1R-mediated signaling inhibition and apoptosis induction in cancer models. Its use is not recommended in diagnostic or clinical settings, nor for long-term solution storage.

• Lysoptosis: Conserved Cell Death Pathway Defined by Serpin M

  2026-04-22

  Luke et al. (2022) identify lysoptosis as a distinct, evolutionarily conserved lysosome-dependent cell death (LDCD) pathway, characterized by lysosomal membrane permeabilization and cathepsin release, and regulated by intracellular serpins. This work clarifies the mechanistic role of cysteine proteases in cell death and has implications for experimental modulation of apoptosis and related pathways.

• CX-5461: Applied Workflows for RNA Polymerase I Inhibition i

  2026-04-22

  CX-5461, a potent RNA polymerase I inhibitor, enables precise interrogation of ribosome biogenesis and solid tumor growth inhibition in translational cancer models. This guide distills recent high-impact findings and offers pragmatic protocols and troubleshooting strategies for maximizing experimental reliability and translational relevance.

• TCF25 Drives Lysosomal Acidification and Cell Death via V-AT

  2026-04-21

  Ren et al. identify TCF25 as a critical nutrient sensor that enhances lysosomal acidification through V-ATPase activity during glucose starvation, orchestrating both metabolic adaptation and lysosome-dependent cell death. These findings offer mechanistic insight into nutrient stress responses and suggest new intervention points for metabolic and ischemic disorders.

• ABT-888 (Veliparib): Advanced PARP Inhibition in MSI Tumor M

  2026-04-21

  Explore the unique mechanisms of ABT-888 (Veliparib) as a potent PARP inhibitor, with an in-depth analysis of its role in DNA repair inhibition and combination therapies for microsatellite instability (MSI) tumor models. Discover differentiated insights, protocol guidance, and the latest scientific findings.

• HyperScript™ Reverse Transcriptase: Unraveling RNA Complexit

  2026-04-20

  Explore how HyperScript™ Reverse Transcriptase empowers precise cDNA synthesis for qPCR, especially in the context of endoplasmic reticulum (ER) stress and complex RNA templates. This article uniquely bridges advanced enzyme technology with cutting-edge stem cell research.

• Coumestrol Induces Ferroptosis in RA Synoviocytes via PMAIP1

  2026-04-20

  This study demonstrates that Coumestrol, a phytoestrogen estrogen receptor antagonist, induces ferroptosis in rheumatoid arthritis fibroblast-like synoviocytes by stabilizing mitochondrial PMAIP1 through TRIM3 inhibition. The findings reveal a novel mechanism for suppressing synovial proliferation and inflammation, highlighting Coumestrol’s promise as a candidate for targeted RA therapies.

• Peptidisc-Enabled Nanobody Multimerization for Polybody Engi

  2026-04-19

  Chen and Duong van Hoa present a peptidisc-assisted strategy for hydrophobic clustering, enabling the assembly of multimeric and multispecific nanobody proteins ('polybodies'). This approach enhances nanobody affinity and versatility, expanding the protein engineering toolkit for advanced biochemical applications.

• Ferritin-Based Hybrid Protein Particles for Combination Vacc

  2026-04-18

  This study introduces a ferritin-based hybrid protein particle vaccine integrating influenza A M2e and SARS-CoV-2 S-protein epitopes into a single nanostructure. The approach enables simultaneous multivalent antigen display and enhances immunogenicity, offering a scalable route to combination vaccine development with robust functional responses.

• Thrombin as a Trypsin-like Serine Protease: Applied Protocol

  2026-04-17

  Unlock the full experimental power of thrombin in coagulation, vascular modeling, and platelet research. This guide details advanced workflows, troubleshooting strategies, and comparative protocol enhancements using APExBIO’s high-purity Coagulation Factor II (Thrombin) B Chain Fragment.

16721 records 1/1115 page Next 12345 下5页 Last page